Fortrea Holdings Inc. Common Stock (FTRE) is a publicly traded Healthcare sector company. As of May 21, 2026, FTRE trades at $13.70 with a market cap of $1.29B and a P/E ratio of -1.25. FTRE moved -0.15% today. Year to date, FTRE is -17.57%; over the trailing twelve months it is +192.11%. Its 52-week range spans $3.97 to $25.28. Analyst consensus is buy with an average price target of $15.58. Rallies surfaces FTRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes FTRE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $13.70 |
| Market Cap | $1.29B |
| P/E Ratio | -1.25 |
| EPS | $-10.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.28 |
| 52-Week Low | $3.97 |
| Volume | 738.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.72B |
| Net Income | $-986.20M |
| Gross Margin | 0.00% |
10 analysts cover FTRE: 0 strong buy, 5 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.58.